Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1

Salvatore Santamaria1, Oleg Fedorov2, John McCafferty3

  • 1a Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Headington , Oxford , UK.

Mabs
|March 18, 2017
PubMed